“Hypofractionated radiation treatment haults cancer growth in high-risk patients.”
51st Annual Meeting of the American Society for Radiation Oncology (ASTRO). 2009 Nov.
This study reveals that when compared with conventional radiation therapy for prostate cancer, hypofractionated radiation is significantly more effective in stopping cancer from growing in high-risk patients, there is no increased risk of negative side effects, and the number of treatment visits can be cut in half. Over a period of about four years, a total of 168 high-risk prostate cancer patients received either hypofractionated or conventional schedules of three-dimensional conformal radiation therapy (3D-CRT). Approximately 87% of patients treated with hypofractionated radiation showed a better chance that their cancer would stop growing.